BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 19563824)

  • 1. Membrane translocation by anthrax toxin.
    Collier RJ
    Mol Aspects Med; 2009 Dec; 30(6):413-22. PubMed ID: 19563824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.
    Sun J; Lang AE; Aktories K; Collier RJ
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4346-51. PubMed ID: 18334631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
    Young JA; Collier RJ
    Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax protective antigen: prepore-to-pore conversion.
    Miller CJ; Elliott JL; Collier RJ
    Biochemistry; 1999 Aug; 38(32):10432-41. PubMed ID: 10441138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient.
    Krantz BA; Finkelstein A; Collier RJ
    J Mol Biol; 2006 Feb; 355(5):968-79. PubMed ID: 16343527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation.
    Wimalasena DS; Cramer JC; Janowiak BE; Juris SJ; Melnyk RA; Anderson DE; Kirk KL; Collier RJ; Bann JG
    Biochemistry; 2007 Dec; 46(51):14928-36. PubMed ID: 18044973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomic structure of anthrax protective antigen pore elucidates toxin translocation.
    Jiang J; Pentelute BL; Collier RJ; Zhou ZH
    Nature; 2015 May; 521(7553):545-9. PubMed ID: 25778700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective antigen component of anthrax toxin forms functional octameric complexes.
    Kintzer AF; Thoren KL; Sterling HJ; Dong KC; Feld GK; Tang II; Zhang TT; Williams ER; Berger JM; Krantz BA
    J Mol Biol; 2009 Sep; 392(3):614-29. PubMed ID: 19627991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of anthrax toxin.
    Lacy DB; Collier RJ
    Curr Top Microbiol Immunol; 2002; 271():61-85. PubMed ID: 12224524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor.
    Pentelute BL; Barker AP; Janowiak BE; Kent SB; Collier RJ
    ACS Chem Biol; 2010 Apr; 5(4):359-64. PubMed ID: 20180595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charge requirements for proton gradient-driven translocation of anthrax toxin.
    Brown MJ; Thoren KL; Krantz BA
    J Biol Chem; 2011 Jul; 286(26):23189-99. PubMed ID: 21507946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation.
    Melnyk RA; Collier RJ
    Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9802-7. PubMed ID: 16785422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthrax protective antigen: efficiency of translocation is independent of the number of ligands bound to the prepore.
    Zhang S; Cunningham K; Collier RJ
    Biochemistry; 2004 May; 43(20):6339-43. PubMed ID: 15147218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic analysis of protein transport through the anthrax toxin channel.
    Basilio D; Kienker PK; Briggs SW; Finkelstein A
    J Gen Physiol; 2011 Jun; 137(6):521-31. PubMed ID: 21624946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.
    Rajapaksha M; Eichler JF; Hajduch J; Anderson DE; Kirk KL; Bann JG
    Protein Sci; 2009 Jan; 18(1):17-23. PubMed ID: 19177347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton-coupled protein transport through the anthrax toxin channel.
    Finkelstein A
    Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):209-15. PubMed ID: 18957378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the pH-dependent prepore to pore transition of Bacillus anthracis protective antigen with differential oxidative protein footprinting.
    Smedley JG; Sharp JS; Kuhn JF; Tomer KB
    Biochemistry; 2008 Oct; 47(40):10694-704. PubMed ID: 18785752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
    Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax toxin protective antigen--insights into molecular switching from prepore to pore.
    Bann JG
    Protein Sci; 2012 Jan; 21(1):1-12. PubMed ID: 22095644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to characterizing single-subunit mutations in multimeric prepores and pores of anthrax protective antigen.
    Janowiak BE; Finkelstein A; Collier RJ
    Protein Sci; 2009 Feb; 18(2):348-58. PubMed ID: 19165720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.